Literature DB >> 5249420

Chromosomes and causation of human cancer and leukemia. V. Karyotypic aspects of acute leukemia.

A A Sandberg, N Takagi, T Sofuni, L H Crosswhite.   

Abstract

Entities:  

Mesh:

Year:  1968        PMID: 5249420     DOI: 10.1002/1097-0142(196811)22:6<1268::aid-cncr2820220626>3.0.co;2-r

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  8 in total

1.  Leukemic xanthomatosis with a missing no. 9 chromosome.

Authors:  F Lampert; C K Phebus; D Huhn; G Meyer; M Greifenegger
Journal:  Z Kinderheilkd       Date:  1972

Review 2.  [Philadelphia chromosome].

Authors:  D K Hossfeld; A A Sandberg
Journal:  Klin Wochenschr       Date:  1970-12-15

3.  [Comparative cytogenetical and quantitative cytochemical DNA studies in acute leukemias].

Authors:  D Müller; D Orywall; N Hübner
Journal:  Blut       Date:  1971-11

4.  A new chromosome anomaly in acute lymphoblastic leukemia (ALL).

Authors:  H Van den Berghe; G David; A Broeckaert-Van Orshoven; A Louwagie; R Verwilghen; M Casteels-Van Daele; E Eggermont; R Eeckels
Journal:  Hum Genet       Date:  1979-01-25       Impact factor: 4.132

5.  Prognostic implications of chromosomal findings in acute lymphoblastic leukaemia at diagnosis.

Authors:  L M Secker-Walker; S D Lawler; R M Hardisty
Journal:  Br Med J       Date:  1978-12-02

6.  Studies in a patient with acute leukaemia after lysergide treatment.

Authors:  O M Garson; M K Robson
Journal:  Br Med J       Date:  1969-06-28

7.  Continuous culture of malignant haemic cells from human acute myelomonocytic leukaemia: cytological, cytochemical, cytogenetic and immunological studies.

Authors:  A Karpas; G Khalid; G F Burns; F G Hayhoe
Journal:  Br J Cancer       Date:  1978-02       Impact factor: 7.640

8.  Null-cell properties of a lymphoid cell line from a child with acute lymphoblastic leukaemia.

Authors:  A Karpas; R M Sandler; R J Thorburn
Journal:  Br J Cancer       Date:  1977-08       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.